CX Institutional’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.03M Buy
151,783
+24,938
+20% +$1.15M 0.25% 89
2025
Q1
$7.74M Sell
126,845
-8,445
-6% -$515K 0.29% 79
2024
Q4
$7.65M Buy
135,290
+3,255
+2% +$184K 0.3% 74
2024
Q3
$6.83M Buy
132,035
+59,116
+81% +$3.06M 0.3% 86
2024
Q2
$3.03M Buy
72,919
+9,892
+16% +$411K 0.14% 164
2024
Q1
$3.42M Sell
63,027
-25,546
-29% -$1.39M 0.16% 151
2023
Q4
$4.54M Buy
88,573
+28,749
+48% +$1.48M 0.24% 107
2023
Q3
$3.47M Sell
59,824
-42,297
-41% -$2.45M 0.19% 133
2023
Q2
$6.53M Buy
102,121
+3,656
+4% +$234K 0.34% 84
2023
Q1
$6.85M Buy
98,465
+82,297
+509% +$5.73M 0.36% 75
2022
Q4
$1.16M Buy
16,168
+2,159
+15% +$155K 0.07% 260
2022
Q3
$996K Sell
14,009
-7,884
-36% -$561K 0.07% 261
2022
Q2
$1.69M Sell
21,893
-24,255
-53% -$1.87M 0.13% 193
2022
Q1
$3.37M Buy
46,148
+41,106
+815% +$3M 0.27% 104
2021
Q4
$314K Sell
5,042
-2,172
-30% -$135K 0.03% 286
2021
Q3
$427K Sell
7,214
-672
-9% -$39.8K 0.03% 275
2021
Q2
$527K Buy
7,886
+1,377
+21% +$92K 0.04% 243
2021
Q1
$411K Buy
6,509
+486
+8% +$30.7K 0.04% 238
2020
Q4
$374K Buy
6,023
+1,034
+21% +$64.2K 0.04% 249
2020
Q3
$301K Buy
4,989
+624
+14% +$37.6K 0.03% 234
2020
Q2
$237K Buy
4,365
+267
+7% +$14.5K 0.03% 236
2020
Q1
$228K Sell
4,098
-148
-3% -$8.23K 0.04% 223
2019
Q4
$273K Buy
4,246
+376
+10% +$24.2K 0.05% 180
2019
Q3
$196K Sell
3,870
-57
-1% -$2.89K 0.03% 215
2019
Q2
$178K Sell
3,927
-715
-15% -$32.4K 0.03% 230
2019
Q1
$221K Buy
4,642
+246
+6% +$11.7K 0.04% 201
2018
Q4
$229K Buy
4,396
+3,200
+268% +$167K 0.05% 158
2018
Q3
$74K Hold
1,196
0.02% 162
2018
Q2
$66K Buy
+1,196
New +$66K 0.02% 141